Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Merck & Co., Inc. and Novartis Pharmaceuticals Corporation.

PEeR Exchange® Assessing Racial and Ethnic Disparities in Lung Cancer Care

Release Date: December 23, 2021
Expiration Date: December 23, 2022


Activity Overview

This PEeR®-Exchange activity features evidence-based presentations on disparities in lung cancer care coupled with discussion from prominent experts on how clinicians can reduce disparities in cancer care for people of color in their own clinics. The activity is designed to improve knowledge and competency around disparities in screening, testing, treatment, and communication for patients with lung cancer.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Merck & Co., Inc. and Novartis Pharmaceuticals Corporation.
 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.



Target Audience

This activity is intended for medical, surgical, and radiation oncologists who treat or manage patients with lung cancer. Other allied oncology health care professionals who are interested in the management of patients with lung cancer are invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Identify strategies to overcome racial disparities in diagnosis, testing, and treatment for patients with lung cancer.
  • Outline racial disparities in outcomes for patients with early-stage or advanced non–small cell lung cancer (NSCLC).
  • Review the incidence of NSCLC in different racial, ethnic, and socioeconomic groups.
  • Determine the implications of emerging treatments in the management of patients with advanced NSCLC across racial, ethnic, and socioeconomic backgrounds.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
 

Chair

Narjust Duma, MD
Narjust Duma, MD
Assistant Professor of Medicine
Thoracic Oncologist
Dana-Farber Cancer Institute
Boston, MA

Disclosures: Grant research support: Siemens, YewSavin, Inc. Consultant: ApcinteX Limited, ASC Therapeutics Inc., Bayer, Biomarin Pharmaceutical, Catalyst Biosciences, CSL Behring, GenVentiv Therapeutics, HEMA Biologics, Freeline Therapeutics, Novo Nordisk, Pfizer, Roche/Genentech, Sangamo Therapeutics, Sanofi, Takeda Pharmaceutical Company, Spark Therapeutics, uniQure.

Faculty

Debora Bruno, MD, MS
Debora Bruno, MD, MS
Assistant Professor of Medicine
Case Western Reserve University
Division of Hematology and Medical Oncology
Co-Chair, Committee on Disparities in Clinical Research
Case Comprehensive Cancer Center/University Hospitals
Cleveland, OH

Disclosures: Debora Bruno, MD, MS, has no relevant financial relationships with ineligible companies.

Estelamari Rodriguez, MD, MPH
Estelamari Rodriguez, MD, MPH
Co-Lead, Thoracic Site Disease Group
Associate Director for Community Outreach
Voluntary Assistant Professor of Clinical Medicine
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Aventura, FL

Disclosures: Consultant: Roche.
 
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
 



Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
27282930
Filter By